Lexicon Pharmaceuticals
LXRX
#8937
Rank
A$0.17 B
Marketcap
$0.47
Share price
-58.17%
Change (1 day)
-86.06%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.02

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.10. In 2022 the company made an earnings per share (EPS) of -$0.98 an increase over its 2021 EPS that were of -$0.98.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.023.66%
2022-$0.98-0%
2021-$0.9810.91%
2020-$0.89-145.08%
2019$1.97-206.09%
2018-$1.86-5.74%
2017-$1.97-10.95%
2016-$2.212640%
2015-$0.08067-96.34%
2014-$2.20-2.53%
2013-$2.26-9.09%
2012-$2.48-37.14%
2011-$3.950%
2010-$3.95-39.66%
2009-$6.553.57%
2008-$6.32-8.2%
2007-$6.89-24.69%
2006-$9.1542.11%
2005-$6.44-22.97%
2004-$8.36-35.09%
2003-$12.87-0%
2002-$12.8762.86%
2001-$7.91-19.54%
2000-$9.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.10 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.28-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.52 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.26-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.75-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.55 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$42.93 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.53-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.21 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA